Cargando…

Accrual, Publication Bias, and the Coronavirus in 2020

The era of COVID19 reflects the importance, perhaps now more than ever, of transparency in the outcomes of trials small and large. The Oncologist Clinical Trial Results (CTR) section has endeavored to provide a remedy for the persistent problem of underreporting in clinical trials in oncology and th...

Descripción completa

Detalles Bibliográficos
Autor principal: Bates, Susan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356711/
https://www.ncbi.nlm.nih.gov/pubmed/32462787
http://dx.doi.org/10.1634/theoncologist.2020-0455
_version_ 1783558548363411456
author Bates, Susan E.
author_facet Bates, Susan E.
author_sort Bates, Susan E.
collection PubMed
description The era of COVID19 reflects the importance, perhaps now more than ever, of transparency in the outcomes of trials small and large. The Oncologist Clinical Trial Results (CTR) section has endeavored to provide a remedy for the persistent problem of underreporting in clinical trials in oncology and the subsequent publication bias that this practice necessarily creates. As The Oncologist celebrates its 25th Anniversary, we focus not only on the ethical and moral imperatives behind CTR, but also on the practical goal of informing the practice of treating physicians.
format Online
Article
Text
id pubmed-7356711
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-73567112020-07-17 Accrual, Publication Bias, and the Coronavirus in 2020 Bates, Susan E. Oncologist Editorials The era of COVID19 reflects the importance, perhaps now more than ever, of transparency in the outcomes of trials small and large. The Oncologist Clinical Trial Results (CTR) section has endeavored to provide a remedy for the persistent problem of underreporting in clinical trials in oncology and the subsequent publication bias that this practice necessarily creates. As The Oncologist celebrates its 25th Anniversary, we focus not only on the ethical and moral imperatives behind CTR, but also on the practical goal of informing the practice of treating physicians. John Wiley & Sons, Inc. 2020-05-29 2020-07 /pmc/articles/PMC7356711/ /pubmed/32462787 http://dx.doi.org/10.1634/theoncologist.2020-0455 Text en © AlphaMed Press 2020
spellingShingle Editorials
Bates, Susan E.
Accrual, Publication Bias, and the Coronavirus in 2020
title Accrual, Publication Bias, and the Coronavirus in 2020
title_full Accrual, Publication Bias, and the Coronavirus in 2020
title_fullStr Accrual, Publication Bias, and the Coronavirus in 2020
title_full_unstemmed Accrual, Publication Bias, and the Coronavirus in 2020
title_short Accrual, Publication Bias, and the Coronavirus in 2020
title_sort accrual, publication bias, and the coronavirus in 2020
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356711/
https://www.ncbi.nlm.nih.gov/pubmed/32462787
http://dx.doi.org/10.1634/theoncologist.2020-0455
work_keys_str_mv AT batessusane accrualpublicationbiasandthecoronavirusin2020